ARC-01（Araris Biotech）

N/A

Report date: 2025/05/14 14:17:08

Base Information

Drug NameARC-01（Araris Biotech）
Drug Alias NameARC-01
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-CD79B
TargetsB-cell antigen receptor complex-associated protein beta chain
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAraris Biotech AG
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesAraris Biotech AG
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A